Shahinaz Gadalla, M.D., Ph.D.
|Organization:||National Cancer InstituteDivision of Cancer Epidemiology & Genetics, Clinical Genetics Branch
|Address:||Executive Boulevard SouthRoom 7030|
BiographyShahinaz Gadalla earned a medical degree from Ain Shams University, Egypt, where she also completed her clinical training. In 2003, Dr. Gadalla joined the epidemiology program at the University of Maryland, Baltimore where she earned a master’s degree in 2005, followed by a Ph.D. in 2008. Dr. Gadalla completed her Ph.D. research project in the Infections and Immunoepidemiology Branch (IIB), DCEG, NCI, under the mentorship of Dr. James Goedert, Senior Investigator, IIB. In that project, she evaluated breast cancer risk among women with systemic rheumatic autoimmune diseases, using the SEER-Medicare linked database. Dr. Gadalla joined the Clinical Genetics Branch (CGB) in September 2008 as a Cancer Prevention Fellow, where she leaded several projects under the mentorship of Drs. Sharon Savage, Investigator, and Mark H Greene, Branch Chief and Senior Investigator. During her postdoctoral training, Dr. Gadalla received an Intramural Research Award for her project titled "Donor and recipient telomere length as predictors of outcomes after hematopoietic stem cell transplant in patients with acquired severe aplastic anemia", and a Merit Award from the Cancer Prevention Fellowship Program. She was promoted to staff scientist in 2011. Her main research interests include identifying populations at high risk of developing cancer, evaluating the role of telomere in human diseases, evaluating cancer prevention strategies, and identifying determinants of cancer outcomes.